Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $966.23 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $164.86 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $159.44 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $144.45 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $121.12 | 1 | $0 (2022) |
| Boston Scientific Corporation | $104.62 | 2 | $0 (2019) |
| Lilly USA, LLC | $87.98 | 3 | $0 (2019) |
| Axonics, Inc. | $70.95 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $26.43 | 2 | $0 (2019) |
| Itamar Medical Inc | $24.69 | 1 | $0 (2022) |
| Arrow International, Inc. | $17.73 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $216.76 | 3 | GlaxoSmithKline, LLC. ($121.12) |
| 2019 | $313.10 | 7 | AstraZeneca Pharmaceuticals LP ($159.44) |
| 2018 | $123.97 | 1 | Daiichi Sankyo Inc. ($123.97) |
| 2017 | $312.40 | 12 | Allergan Inc. ($164.86) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $121.12 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $70.95 | General |
| Category: Urology | ||||||
| 03/28/2022 | Itamar Medical Inc | WatchPAT (Device) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: Sleep Apnea testing | ||||||
| 07/30/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $61.99 | General |
| Category: Oncology | ||||||
| 05/30/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Oncology | ||||||
| 05/23/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $66.95 | General |
| Category: STRUCTURAL HEART | ||||||
| 05/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/28/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Anemia | ||||||
| 11/15/2017 | Arrow International, Inc. | VPS - Arrow (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Vascular Access | ||||||
| 11/09/2017 | Allergan Inc. | NAMENDA XR (Drug), NAMZARIC | Food and Beverage | In-kind items and services | $139.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Anemia | ||||||
| 09/19/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Endocrinology | ||||||
| 08/17/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DIABETES | ||||||
| 04/26/2017 | BOSTON SCIENTIFIC CORPORATION | AMS 700 (Device) | Food and Beverage | In-kind items and services | $37.67 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 04/25/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/25/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/23/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 02/21/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 805 | 1,611 | $294,153 | $130,644 |
| 2022 | 19 | 952 | 2,016 | $359,876 | $162,065 |
| 2021 | 20 | 1,013 | 2,066 | $355,795 | $172,819 |
| 2020 | 23 | 1,136 | 2,240 | $378,157 | $158,649 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 963 | $211,860 | $86,998 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $24,480 | $19,576 | 80.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 193 | $31,845 | $12,236 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 30 | $9,150 | $3,620 | 39.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 77 | 77 | $2,695 | $2,328 | 86.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,140 | $1,378 | 33.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 18 | $2,124 | $952.20 | 44.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 43 | 43 | $1,720 | $941.70 | 54.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 28 | 28 | $1,105 | $904.23 | 81.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 18 | $1,836 | $738.36 | 40.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 48 | $1,920 | $479.35 | 25.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 13 | $1,053 | $458.16 | 43.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 15 | $225.00 | $33.00 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 267 | 1,094 | $240,680 | $101,560 | 42.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 152 | 152 | $24,320 | $19,793 | 81.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 188 | $31,020 | $12,552 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 49 | $14,945 | $6,910 | 46.2% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 15 | 83 | $16,351 | $6,884 | 42.1% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 14 | 25 | $4,000 | $2,418 | 60.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 73 | 73 | $2,920 | $2,307 | 79.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 74 | 74 | $2,590 | $2,121 | 81.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,245 | $1,943 | 26.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 23 | 32 | $2,592 | $1,080 | 41.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 15 | 22 | $2,596 | $922.64 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,688 | $810.68 | 30.2% |
About Dr. Amir Shirmohammad, M.D
Dr. Amir Shirmohammad, M.D is a Family Medicine healthcare provider based in Trinity, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912060500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Shirmohammad, M.D has received a total of $966.23 in payments from pharmaceutical and medical device companies, with $216.76 received in 2022. These payments were reported across 23 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($966.23).
As a Medicare-enrolled provider, Shirmohammad has provided services to 3,906 Medicare beneficiaries, totaling 7,933 services with total Medicare billing of $624,176. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Trinity, FL
- Active Since 12/18/2006
- Last Updated 04/27/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912060500
Products in Payments
- LOKELMA (Drug) $159.44
- INJECTAFER (Drug) $144.45
- NAMENDA XR (Drug) $139.42
- BENLYSTA (Biological) $121.12
- VERZENIO (Drug) $73.77
- Axonics (Device) $70.95
- WATCHMAN (Device) $66.95
- AMS 700 (Device) $37.67
- WatchPAT (Device) $24.69
- BYSTOLIC (Drug) $23.16
- VPS - Arrow (Device) $17.73
- Prolia (Biological) $17.68
- TRULICITY (Drug) $14.21
- INVOKANA (Drug) $13.49
- JARDIANCE (Drug) $13.44
- XARELTO (Drug) $12.94
- Victoza (Drug) $12.84
- NAMZARIC (Drug) $2.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Trinity
Dr. Tatiana Hernandez, Md, MD
Family Medicine — Payments: $37,394
Elizabeth Carson, M.d, M.D
Family Medicine — Payments: $6,718
Dr. Daniel Rodriguez, M.d, M.D
Family Medicine — Payments: $5,459
Dr. Jonathan Nagy, M.d, M.D
Family Medicine — Payments: $4,396
Elizabeth Kolawole, Md, MD
Family Medicine — Payments: $1,810
Dr. Matthew Bruneau, M.d, M.D
Family Medicine — Payments: $1,489